← All organizations
Kangbuk Samsung Hospital
Academic/HospitalWebsite ↗
Also known as: Dong Il Park, M.D, Ph.D. | Eunah Cho, MD | Ho Cheol Shin, M.D., Ph.D. | Kangbuk Samsung Hospital | Kangbuk Samsung Hospital, Seoul, Republic of Korea | KYU-SUNG LEE | Samsun Education and Research Hospital | Samsung Medical Center, Seoul, Republic of Korea | samsung seoul medical center | Seok Jin Kim
Highest phase reached
Phase 4
First clinical trial
Jun 1, 2008Last known activity
Sep 22, 2025
Timeline
1960s
- Jan 1, 1968
Kangbuk Samsung Hospital— Founded
Drugs by trial phase (63 distinct, 54 trials)
Phase 4 (13 own, 0 via acquisition)
Phase 3 (15 own, 0 via acquisition)
Phase 2 (18 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Other trials (13 own, 0 via acquisition)
Indications
Studied for
- Amyotrophic Lateral Sclerosis
- Cholangitis
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Dyspepsia
- Essential Hypertension
- Fatigue
- Fatigue Syndrome, Chronic
- Genital Diseases, Female
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hypertension
- Intermittent Claudication
- Intervertebral Disc Degeneration
- Liver Diseases
- Lymphoma
- Lymphoma, Mantle-Cell
- Motor Neuron Disease
- Musculoskeletal Diseases
- Peripheral Arterial Disease
- Sclerosis
- Spinal Diseases
- Stomach Neoplasms
- Syndrome
- Ureteral Calculi
- Ureterolithiasis
- Urinary Bladder, Overactive
Recent trials (50)
- NCT07192263OfficialPhase 3Sep 22, 2025
- NCT06062030Overall official - principal investigatorPhase 3Nov 30, 2023
- NCT05845489CollaboratorPhase 4Mar 9, 2023
- NCT05640830Reponsible party - principal investigatorPhase 1/Phase 2Jan 1, 2023
- NCT05640830Overall official - principal investigatorPhase 1/Phase 2Jan 1, 2023
- NCT05640830Lead sponsorPhase 1/Phase 2Jan 1, 2023
- NCT05538741Reponsible party - principal investigatorN/ADec 31, 2022
- NCT05538741Lead sponsorN/ADec 31, 2022
- NCT05356091Reponsible party - principal investigatorN/ADec 2, 2022
- NCT05356091Lead sponsorN/ADec 2, 2022
- NCT05356091Sponsor investigatorN/ADec 2, 2022
- NCT05536323Overall official - principal investigatorN/ANov 1, 2022
- NCT05536323Reponsible party - principal investigatorN/ANov 1, 2022
- NCT05536323Lead sponsorN/ANov 1, 2022
- NCT06592365OfficialN/AAug 8, 2022
Details
- Founded
- Seoul, KR Jan 1, 1968
- Last known activity
- Sep 22, 2025